Stocktoria

Pulmatrix, Inc. PULM

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-03-21 · LEI

Pulmatrix, Inc. statistics & valuation

P / B1.6×
Return on capital-135.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-2978.00% -5216.40% -13333.30% -261.60% -78.10% -390.20% -312.10% -202.00% -125.10% 2016201720182019202020212022202320242025
Return on equity (%)
-317.80% -178.10% -173.60% -186.90% -83.40% -42.50% -60.50% -78.50% -106.80% -135.50% 2016201720182019202020212022202320242025
Shares outstanding
14.9M 2.1M 4.9M 20.0M 1.8M 3.2M 3.45B 3.7M 3.7M 3.7M 2016201720182019202020212022202320242025
Net debt ($)
-$965000 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-167.10% -113.00% -139.70% -57.10% -50.70% -34.30% -46.00% -41.60% -96.10% -124.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-1640.50% -4343.60% -10967.30% 40.10% -101.00% -384.40% -320.20% -228.30% -142.40% 2016201720182019202020212022202320242025
Debt / equity (×)
0.37× 2016201720182019202020212022202320242025
EPS ($)
-$5.46 -$3.87 -$2.62 -$1.41 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-125.1%-202.0%-312.1%-390.2%-78.1%-261.6%-13333.3%-5216.4%-2978.0%
Net margin-122.5%-193.5%-310.3%-390.2%-152.8%-260.4%-13439.9%-5389.9%-3334.5%
FCF margin-142.4%-228.3%-320.2%-384.4%-101.0%40.1%-10967.3%-4343.6%-1640.5%
Return on assets-124.7%-96.1%-41.6%-46.0%-34.3%-50.7%-57.1%-139.7%-113.0%-167.1%
Return on equity-135.5%-106.8%-78.5%-60.5%-42.5%-83.4%-186.9%-173.6%-178.1%-317.8%
Debt / equity0.37×
Current ratio12.5510.685.337.6012.333.971.831.140.731.02

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.